Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2013
08/08/2013WO2013113716A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113715A1 Fungicidal pyrimidine compounds
08/08/2013WO2013113669A1 Isoquinoline and naphthyridine derivatives
08/08/2013WO2013083975A3 Novel pyrrole derivatives
08/08/2013US20130204002 Process for the preparation of dexlansoprazole
08/08/2013US20130203990 Process for the preparation of imatinib mesylate
08/08/2013US20130203987 Ampk-activating heterocyclic compounds and methods for using the same
08/08/2013US20130203904 Sterically hindered polymeric amines and their use as polymer stabilizers
08/08/2013US20130203821 Pyridine Compounds for Controlling Invertebrate Pests II
08/08/2013US20130203818 Compounds that modulate intracellular calcium
08/08/2013US20130203806 Cilostazol cocrystals and compositions
08/08/2013US20130203774 Novel compounds, use and preparation thereof
08/08/2013US20130203768 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
08/08/2013US20130203767 Treatment of Pulmonary Hypertension
08/08/2013US20130203763 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
08/08/2013US20130203758 Compounds for the Treatment of Hepatitis C
08/08/2013US20130203750 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
08/08/2013US20130203749 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
08/08/2013US20130203747 Inhibitors of human immunodeficiency virus replication
08/08/2013US20130203732 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
08/08/2013US20130203728 Pyrrolidine compounds
08/08/2013US20130203656 Inhibitors of hcv ns5a
08/08/2013US20130203593 Pesticidal compositions and processes related thereto
08/08/2013US20130203592 Pesticidal compositions and processes related thereto
08/08/2013US20130202573 Thioacetate compounds, compositions and methods of use
08/08/2013US20130200359 Triphenylene-based materials for organic electroluminescent devices
08/07/2013EP2623504A1 5,6-Disubstituted oxindole derivatives and their use in the manufacture of a medicament for the treatment of vasopressin-dependent diseases
08/07/2013EP2623493A1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators
08/07/2013EP2623492A1 Cyclohexane derivative compound
08/07/2013EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
08/07/2013EP2621917A1 Crystalline oxalate salts of a diamide compound
08/07/2013EP2621916A1 Benzazole derivatives as histamine h4 receptor ligands
08/07/2013EP2621915A2 Novel method of preparing benzoimidazole derivatives
08/07/2013EP2621914A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
08/07/2013EP2621913A1 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators
08/07/2013EP2621908A2 Manufacturing process for pyrimidine derivatives
08/07/2013EP2621907A1 Fungicidal imidazoles
08/07/2013CN103237800A Amide derivative and use thereof
08/07/2013CN103237799A Heterocyclic derivates, preparation processes and medical uses thereof
08/07/2013CN103237798A Substituted benzimidazole and imidazopyridine compounds used as CYP17 modulators
08/07/2013CN103237797A Quinolin-4 (1h)-ketone derivatives as inhibitors of phosphatidylinositol 3-kinases
08/07/2013CN103237794A P2X4 receptor antagonist
08/07/2013CN103237790A Novel methylcyclohexane derivatives and uses thereof
08/07/2013CN103232444A Naphthoquine derivatives, and preparation and application thereof
08/07/2013CN103232440A Preparation method and application of sym-triazole bi-Schiff base compound
08/07/2013CN103232439A N-heterocyclic methyl tetrahydropyridine-5-substituted indole and preparation method and application thereof
08/07/2013CN103232438A Pantoprazole sodium and preparation method thereof
08/07/2013CN103232437A Preparation method of rabeprazole sodium crystal type compound
08/07/2013CN103232436A Preparation method of lansoprazole crystal type compound
08/07/2013CN103232435A Cis nitenpyram analogue containing chiral arm as well as preparation method and application thereof
08/07/2013CN103232434A Nicotine compound, preparation method and uses thereof
08/07/2013CN103232433A N-substituted benzyl tetrahydropyridine with indole and preparation method and application thereof
08/07/2013CN103232432A 3-difluoroethoxy-4-chloropyrazole amide compound and use thereof
08/07/2013CN103232431A Dihalogenated pyrazole amide compound and its use
08/07/2013CN102827147B Omeprazole sodium crystal compound and medicine composition containing omeprazole sodium crystal compound
08/07/2013CN102329300B Method for preparing imatinib
08/07/2013CN102171205B Pyrazinone modulator of corticotropin-releasing factor receptor activity
08/07/2013CN102149705B [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1H-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
08/07/2013CN102056902B Imidazolidine derivatives
08/07/2013CN102020633B Method for preparing 1-(3,5- dichloropyridine-2-yl)-pyrazolecarboxamide compounds
08/07/2013CN101896479B Process for the preparation of pyrido [2,1-a] isoquinoline derivatives
08/07/2013CN101679366B Pyridyl piperidine orexin receptor antagonists
08/07/2013CN101595102B Biaryl ether urea compounds
08/07/2013CN101448816B Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/06/2013US8501951 Process for producing amide compound
08/06/2013US8501950 N-cyanoalkylanthranilamides as insecticides
08/06/2013US8501787 Compounds for the inhibition of angiogenesis and use thereof
08/06/2013US8501786 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
08/06/2013US8501784 2-pyridone derivatives as neutrophil elastase inhibitors and their use
08/06/2013US8501782 Piperidinyl derivatives as modulators of chemokine receptor activity
08/06/2013US8501780 Indazole carboxamides and their use
08/06/2013US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
08/06/2013US8501776 Biphenyl compounds useful as muscarinic receptor antagonists
08/06/2013US8501773 4-fluoro-piperidine T-type calcium channel antagonists
08/06/2013US8501757 Substituted phenylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
08/06/2013US8501754 Quinazolinamide derivatives
08/06/2013US8501747 Functionally selective alpha2C adrenoreceptor agonists
08/06/2013US8501745 Piperazine PDE4 inhibitors and uses thereof
08/06/2013US8501740 Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors
08/06/2013US8501739 Medicaments
08/06/2013US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/06/2013US8501736 Isoquinoline derivatives
08/06/2013US8501732 Aminomethyl quinolone compounds
08/06/2013US8501731 Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity
08/06/2013US8501238 Anti-infective agents and uses thereof
08/06/2013CA2758251C Serotonin and norepinephrine reuptake inhibitor
08/06/2013CA2752421C Amino ester derivatives, salts thereof and methods of use
08/06/2013CA2679852C Method for producing quinolone carboxylic acid derivative
08/06/2013CA2674347C Solid state forms of racemic ilaprazole
08/06/2013CA2654945C Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
08/06/2013CA2646624C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/06/2013CA2588513C 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/06/2013CA2586271C Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors
08/06/2013CA2586265C Nicotinamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors
08/06/2013CA2570499C Method for producing 4-(benzimidazolylmethylamino)-benzamidines
08/06/2013CA2567513C Histamine h3 receptor agents, preparation and therapeutic uses
08/06/2013CA2560653C Angiogenesis inhibitors and uses thereof
08/06/2013CA2557942C 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
08/06/2013CA2557304C Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
08/06/2013CA2531859C Benzimidazole derivatives as raf kinase inhibitors
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 1080